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A B S T R A C T
There appears to be some inconsistency in how normal sleepers (controls) are selected and screened for
participation in research studies for comparison with insomnia patients. The purpose of the current study
is to assess and compare methods of identifying normal sleepers in insomnia studies, with reference to
published standards. We systematically reviewed the literature on insomnia patients, which included
control subjects. The resulting 37 articles were systematically reviewed with reference to the ﬁve cri-
teria for normal sleep speciﬁed by Edinger et al. [2]. In summary, these criteria are as follows: evidence
of sleep disruption, sleep scheduling, general health, substance/medication use, and other sleep disor-
ders. We found sleep diaries, polysomnography (PSG), and clinical screening examinations to be widely
used with both control subjects and insomnia participants. However, there are differences between re-
search groups in the precise deﬁnitions applied to the components of normal sleep. We found that none
of the reviewed studies applied all of the Edinger et al. criteria, and 16%met four criteria. In general, screen-
ing is applied most rigorously at the level of a clinical disorder, whether physical, psychiatric, or sleep.
While the Edinger et al. criteria seem to be applied in some form by most researchers, there is scope to
improve standards and deﬁnitions in this area. Ideally, different methods such as sleep diaries and ques-
tionnaires would be used concurrently with objective measures to ensure normal sleepers are identiﬁed,
and descriptive information for control subjects would be reported. Here, we have devised working cri-
teria and methods to be used for the assessment of normal sleepers. This would help clarify the nature
of the control group, in contrast to insomnia subjects and other patient groups.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Given the signiﬁcance of sleep to well-being [1], consistency in
how research participants are selected is important. Indeed, this is
accepted among clinicians, with diagnostic systems used to iden-
tify different sleep disorders [2–4]. While it is acknowledged that
adherence to consensus categorization systems is important with
clinical groups, such high standards have not always been applied
to the selection of normal sleepers (controls). As a result, the precise
deﬁnitions, and consequently methods, applied to identify normal
sleepers are variable within sleep research. The purpose of the
current study was to investigate exactly how control subjects are
assessed, in comparison to insomnia patients. The selection of control
subjects is important, as group differences may be caused by these
subjects rather than the patient group, if normal sleepers are not
well deﬁned and selected. Furthermore, consistency in how normal
sleepers are deﬁned is important in order to compare results between
studies. These results have broader implications for the selection
of normal sleepers or control subjects within sleep research overall.
A deﬁnition of normal sleepers (controls) has been provided, and
ﬁve criteria have been identiﬁed. The research diagnostic criteria
(RDC) for normal sleepers speciﬁes that normal sleepers should show
no evidence of sleep disruption (Criterion A) and that the timing
of sleep should be both regular and conventional (Criterion B) [2].
As such, both the quality of sleep and its timing are thought to be
important in deﬁning normal sleepers. However, these compo-
nents of normal sleep are not always applied in practice. For example,
the Pittsburgh Sleep Quality Index (PSQI) [5], and the Insomnia Se-
verity Index (ISI) [6], have been used to categorize participants as
poor and normal sleepers [7–11]. In this approach, those partici-
pants scoring below threshold are categorized as normal sleepers.
* Corresponding author. 58 Hillhead Street, Glasgow G12 8QB, UK. Tel.: +44 (0)141
330 5085; fax: +44 (0)141 330 4606.
E-mail address: l.beattie.1@research.gla.ac.uk (L. Beattie).
http://dx.doi.org/10.1016/j.sleep.2015.01.010
1389-9457/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
Sleep Medicine 16 (2015) 669–677
Contents lists available at ScienceDirect
Sleep Medicine
journal homepage: www.elsevier.com/ locate /s leep
Others seem to deﬁne acceptable levels of sleep disruption or to
select healthy subjects based on the absence of insomnia disorder
rather than the presence of normal or good sleep. However, such
differences in methods may lead to different groups being used as
a comparison, with some subjects being better sleepers than others.
Furthermore, evidence of sleep disruption is only one component
of research diagnostic criterion for control subjects [2].
The second component of research diagnostic criterion for control
subjects includes two elements. First, sleep timing is conventional
[2]. Some authors specify habitual bedtimes and rise times as in-
clusion criteria. This is also pertinent to circadian rhythm sleep
disorders (CRSDs), and an individual’s preference for morningness
or eveningness is relevant to their sleep scheduling. The
morningness–eveningness questionnaire (MEQ) was developed to
assess diurnal preference [12], and it has been used to identify
morning and evening types [13–17]. Second, the RDC also speci-
ﬁes that the timing of sleep is stable. Sleep diaries can be used to
monitor adherence to a sleep schedule [15,18,19], and assess re-
ported sleep patterns and habits, as well as their variability [20–22].
They provide information about the daily timing of sleep, as well
as measures of sleep continuity (eg, wake after sleep onset), and
its qualitative experience, and sleep diaries are regarded as the “gold
standard” in measuring subjective sleep experience [23]. However,
while a routine sleep schedule is thought to be important to normal
sleep [24,25], there seems to be a lack of clarity as to how much
variability in sleep scheduling is acceptable in practice.
To fully understand the development and maintenance of sleep
disorders, such as insomnia, it is necessary to understand the pro-
cesses in normal sleep [24–26]. However, this is hampered when
the methods of assessment of normal sleepers differ, and this seems
especially pertinent when research subjects are recruited from a
student population, whose sleep can be irregular and of poor quality
[27]. A majority of potential participants (ie, normal sleepers) might
be expected to show a moderate level of vulnerability towards poor
sleep or insomnia, in keeping with a normal distribution (eg, Yiend
[28]). When insomnia subjects and normal sleepers are compared
on the effects of poor sleep, the daytime effects of poor sleep are
similar, although more severe for insomnia patients [29], and both
groups use comparable criteria to judge sleep quality [30]. However,
in insomnia patients, the daytime effects associated with sleep seem
especially important, both in theory [25,31] and to patients them-
selves [29,32]. Current research is aimed at investigating the etiology
of insomnia disorder, for example, the development of chronic in-
somnia from acute insomnia [33], and this suggests the importance
of additional factors in the development of insomnia disorder. For
example, insomnia patients might experience the effects of sleep
disruptionmore severely or reportmore frequent nights of poor sleep
[28], and changes in sleep architecture could contribute towards this
transition [33]. Furthermore, in keeping with a normal distribu-
tion [28], some normal sleepers could show evidence of sleep
disruption, while not quite endorsing insomnia (eg, Ref. [25]). Normal
sleepers could also be different from good sleepers, who would be
expected to report good sleep without sleep disruption. Although
investigating the differences between good sleep and normal sleep
is beyond the scope of the current paper, understanding deﬁni-
tions applied to control subjects seems an important ﬁrst step. As
such, we have conducted a systematic review on how control sub-
jects are assessed for study inclusion within insomnia research. We
then outline recommendations for assessing normal sleep, and we
suggest methods of assessment.
2. Methods
A literature search was conducted within six key sleep society-
aﬃliated journals. In particular, Sleep is the oﬃcial publication of
the Associated Professional Sleep Societies, the Journal of Sleep
Research is published on behalf of the European Sleep Research
Society, and Sleep Medicine is the oﬃcial journal of the World As-
sociation of Sleep Medicine and International Pediatric Sleep
Association. Behavioral Sleep Medicine is the oﬃcial journal of the
Society of Behavioral Sleep Medicine; Chronobiology International
is the oﬃcial journal for the International Society for Chronobiology,
the American Association for Medical Chronobiology and
Chronotherapeutics, and the Society for Light Treatment and Bio-
logical Rhythms. The Journal of Biological Rhythms is the oﬃcial
publication of the Society for Research on Biological Rhythms. The
Journal of Clinical Sleep Medicine, an oﬃcial publication of the Amer-
ican Academy of Sleep Medicine, was not included due to a lack of
institutional access. The literature search was conﬁned to these jour-
nals, as they were expected to apply more stringent criteria towards
how sleep groups are deﬁned. The anticipated effect of this was to
bias the literature search towards more conservative or stringent
methodologies with respect to sleep.
The “Web of Knowledge” (http://wok.mimas.ac.uk/) search
engine was used to access database entries for these journals. The
key search terms were “poor sleep” or “insomnia,” and a large
number of results were found initially (24,782 search results).
These results were ﬁltered by selecting article types that were
published in English, and we selected those studies based on
adults (see Fig. 1). We further reﬁned these results to identify
those papers where an insomnia sample was compared against
controls, and 64 abstracts were then manually reviewed (Fig. 1).
These papers were all published from 2005 until present, follow-
ing the publication of the RDC in 2004. As the focus of this review
was on methods of assessment, sample size was not considered
as an exclusion criterion.
Papers without a suitable control group were excluded (eg, in-
tervention studies), giving a ﬁnal sample of 37 (Table 1). All papers
included an insomnia patient group, and the majority (30) used pa-
tients with primary insomnia. Data were extracted by selecting those
methods relevant to each of the ﬁve criteria in the RDC [2]. In general,
speciﬁc details as to insomnia andmethods of sleep assessment were
coded within Criterion A. Information relevant to CRSDs and test
time, as well as work and travel, was contained within Criterion B.
In keeping with the RDC, methods relevant to physical and psychi-
atric health, medication use and substance abuse, and sleep disorders
in general were coded separately under Criteria C, D, and E. All data
were coded as described in the original papers, and not subject to
interpretation at initial encoding.
3. Results
3.1. Criterion A
We recorded how control groups were deﬁned with regard to
Criterion A, that is, “the individual has no complaints of sleep dis-
turbance or daytime symptoms attributable to unsatisfactory sleep.”
First, the deﬁnitions applied to control subjects are summarized.
These deﬁnitions varied from “healthy” to “normal/good sleepers”
to “typically good sleepers,” and they included descriptions such
as no subjective complaints of sleep diﬃculties or insomnia, or sleep
or insomnia complaints. More detailed deﬁnitions included sub-
jects characterizing their sleep as restorative or refreshing, sleep
satisfaction, relatively imperturbable sleep, and falling asleep as soon
as their head touches the pillow. Additional speciﬁcations in-
cluded that subjects report no history of sleep disorders or insomnia,
either currently or in the past, and objective sleep thresholds were
also used. Sleep questionnaires can be used to quantify sleep-
related thresholds, and 5% of studies reported cutoff scores or
descriptive information for the PSQI, with the ISI similarly used
by 30% of papers. Many studies (51%) reported sleep diary
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parameters of control subjects, and a majority of studies (65%) re-
ported descriptive sleep information from polysomnographic (PSG)
measures, with two studies (5%) reporting actigraphy-derived sleep
parameters.
In terms of meeting Criterion A, we required papers to have ex-
plicit exclusion criteria based on both measures of sleep disruption
(i.e., sleep continuity) and daytime effects (eg, report sleep as re-
storative). In total, 8% of papers met this criterion.
3.2. Criterion B
Criterion B is deﬁned as an individual having “a routine stan-
dard sleep/wake schedule characterized by regular bedtimes and
rising times.” To assess this, we recorded information relevant to
sleep timing within the articles. Four studies (11%) reported average
bedtimes/rise times, and the range of subjects’ sleep timing was re-
ported by 30% of studies, either descriptively or as inclusion criterion
(eg, to conﬁrm consistency of habitual sleep patterns with a speci-
ﬁed sleep laboratory schedule). One study reported an actigraphy-
derived measure of the circadian phase, and another reported a
measure of diurnal preference. Other relevant exclusion criteria in-
cluded shift-working patterns and long-range travel, as well as CRSDs
or abnormal usual sleep schedules. With regard to meeting crite-
ria for sleep timing, adherence to this criterion was deﬁned by
explicit exclusion criteria for sleep timing, that is, bedtimes and rise
times, and met by 30% of papers.
3.3. Criterion C
Criterion C is deﬁned as “no evidence of a sleep-disruptive
medical or mental disorder.”
A majority of studies applied general medical examinations,
which were used to assess health, and the absence of signs or symp-
toms of a disorder (eg, blood screening tests). Twelve studies (32%)
also reported body mass index (BMI) scores, and 56% used or re-
ported data from additional questionnaire screening measures for
symptoms of mental health conditions, such as depression or anxiety.
At least one medical condition was excluded for by 84% of studies,
and speciﬁc disorders listed included unstable hypertension, thyroid
disorders, seizure disorders, neurodegenerative disease, chronic pain,
signiﬁcant head trauma or loss of consciousness, cardiovascular or
respiratory disease, diabetes, dementia, multiple sclerosis, preg-
nancy, hepatitis, cancer, Parkinson’s disease, rheumatoid arthritis,
gastroesophageal reﬂux disease, asthma, and chronic obstructive pul-
monary disease. At least one psychiatric disorder was excluded for
by 86% of studies, which included mood disorders, psychotic dis-
orders, anxiety disorders, eating disorders, somatoform disorders,
and substance abuse disorder (the latter is considered in more detail
under Criterion D). When this criterion was judged via exclusions
for medical and psychiatric disorders, 70% of papers met this
criterion.
3.4. Criterion D
Criterion D is deﬁned as “no evidence of sleep disruption due
to a substance exposure, use, abuse, or withdrawal.” Generally, ar-
ticles assessed subjects for evidence of a disorder that would be
relevant to this criterion. In total, 76% of articles reported exclu-
sion criteria as to medication use, and these articles most commonly
selected subjects who were not on medication, not using medica-
tion affecting sleep, or taking CNS-active agents, psychotropic agents,
or hypnotics. Drug abuse or dependence was excluded by 57% of
studies, with alcohol, caffeine, or nicotine consumption men-
tioned by 59% of articles. When Dwas deﬁned as explicit exclusions
for substance abuse andmedication use, 43% of studiesmet criterion.
3.5. Criterion E
The ﬁnal criterion is “no evidence of a primary sleep disorder.”
A number of studies (59%) reported PSG screening for sleep apnea
and limb movements in control subjects. Evidence of sleep disrup-
tion, or other sleep disorders, was assessed by 76% of articles and
included evidence of current disorder, evidence of symptoms, and/
or past (or family) history. In addition, other disorders (e.g., nocturia,
enuresis, and bruxism) were mentioned occasionally. When this
Fig. 1. Literature search strategy.
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criterion was deﬁned as explicit exclusion criteria for sleep disor-
ders in conjunction with PSG, 54% of papers met criteria.
In total, no papers were judged to meet all ﬁve criteria. Sixteen
percent met four criteria, 24% of papers met three criteria, 27% met
two criteria, and 14%met one criterion, with 19% of papers meeting
none. The complete table as to how papers were coded is avail-
able online in Appendix S1.
4. Discussion
Overall, the selected articles screened subjects well for poten-
tial disorders (whether physical, psychiatric, or sleep). However, the
criteria applied to control subjects differed between studies, and in-
formation relevant to criteria seemed to be used to describe subject
groups, rather than as explicit a priori exclusion criteria. There are
also differences between laboratories as to how exactly subjects are
identiﬁed, and Criteria A and B seem to require clarity. While Edinger
et al. [2] deﬁne A as “no complaints of sleep disturbance, or daytime
symptoms attributable to poor sleep,” there is a lack of consensus
as to how exactly this should be deﬁned. For example, some specify
sleep diary criteria, while others use questionnaire cutoffs, and/or
a lack of “sleep complaint,” or absence of insomnia disorder as such.
We would interpret A as comprising three main elements: ﬁrst,
whether an individual is experiencing sleep disturbance (ie, via sleep
duration or sleep continuity measures); second, whether subjects
are satisﬁed with their sleep and experience good sleep quality; and
third, the experience of adverse sleep-related daytime effects leading
to the exclusion of control subjects.
Criterion B, deﬁned as “a routine standard sleep/wake sched-
ule characterized by regular bedtimes and rising times,” [2] seems
to comprise several components, in particular, the habitual timing
of sleep and its stability. Evidence of CRSDs often seemed to be used
to assess this criterion, overlapping with Criterion E. While a ma-
jority of authors reported the use of sleep diaries, which can be used
to assess this, it is often unclear exactly how these components are
deﬁned in practice. Many authors deﬁned normal sleep timing pa-
rameters, although normality would seem to depend on the study
sample andwould be affected, for example, by age [34]. Sleep timing,
chronotype, and sleep quality seem to be interlinked [35–37]. Fur-
thermore, while the stability of sleep timing seems to be important
for control subjects, this component seems to be rarely directly ad-
dressed, other than by shift work, and it is unclear whether any
exclusions were made based on sleep timing stability as such. The
variability, or stability, of sleep timing could also contribute to good
sleep (eg, Ref. [25]), and differences in sleep timing between the
working week and at the weekend could contribute to variability
in sleep timing [38] and social jet lag [39,40]. Questionnaire mea-
sures such as the Sleep Timing Questionnaire [38] (STQ) could be
used to quantify the components of sleep timing, as could mea-
sures derived from sleep diary parameters. We would deﬁne B as
conventional (for a particular population) bedtimes and rise times,
which are consistent (±1 h, at least four days a week).
For the remaining criteria, there seems to be some ambiguity
as to the precise deﬁnitions. Furthermore, clear deﬁnitions are
needed in order to standardize methods andmeasures. For example,
we would interpret C as a currently diagnosable serious medical or
Table 1
Summary of papers meeting inclusion criteria.
First Author Year Control N Age Gender Insomnia patients
1 Bastien 2013 30 35.8 (9.1) 18 F, 12 M Psychophysiological insomnia,
paradoxical insomnia
2 Huang 2012 48 38 (12) 28 F, 20 M Primary insomnia
3 Israel 2012 22 26.5 (7.3) 19 F, 3 M Primary insomnia
4 Morgan 2012 17 36 (9) 9 F, 8 M Primary insomnia
5 Corsi-Cabrera 2012 10 25.6 (4.6) 5 F, 5 M Primary insomnia
6 Forget 2011 12 44.3 (9.4) 7 F, 7 M Primary insomnia
7 De Zambotti 2011 8 23.23 (3.24) 5 F, 3 M Primary insomnia
8 Nissen 2011 53 46.9 (4.65) 32 F, 21 M Primary insomnia
9 Spiegelhalder 2011 46 37.3 (11.4) 27 F, 19 M Primary insomnia
10 Manconi 2010 288 58.5 (7.23) 176 F, 112M Primary insomnia
11 Winkelman 2010 15 38.8 (5.3) 6 F, 9 M Primary insomnia
12 Deuschle 2010 827 54.6 (17.2) 455 F, 372 M Primary insomnia
13 Spiegelhalder 2010 30 48.3 (12.9) 21 F, 9 M Primary insomnia
14 Parrino 2009 20 45 (8) 16 F, 4 M Paradoxical insomnia
15 Lanfranchi 2009 13 42 (9) 9 F, 4 M Primary insomnia
16 Buysse 2008 25 30.6 (7.4) 15 F, 10 M Primary insomnia
17 Winkelman 2008 16 37.6 (4.5) 7 F, 9 M Primary insomnia
18 Feige 2008 100 41.12 (13.99) 54 F, 36 M Primary insomnia
19 Spiegelhalder 2008 20 38.6 (10.1) 12 F, 8 M Primary insomnia
20 Bastien 2008 16 36.81 (10.19) 10 F, 6 M Psychophysiological insomnia
21 Edinger 2008 84 48.6 (16.8) 41 F, 43 M Primary insomnia
22 Sagaspe 2007 13 45 (12) 5 F, 8 M Psychophysiological insomnia
23 Orff 2007 17 36.1 (7.1) 13 F, 4 M Primary insomnia
24 Riemann 2007 8 46.3 (14.3) 5 F, 3 M Primary insomnia
25 Robertson 2007 15 27.7 (7.05) 8 F, 7 M Psychophysiological insomnia
26 Yang 2007 15 34.3 (12.9) 10 F, 5 M Primary insomnia
27 Buysse 2007 18 27.2 (7.9) 15 F, 3 M Primary insomnia
28 MacMahon 2006 20 28.2 (10.1) 11 F, 9 M Primary insomnia
29 Ouellet 2006 14 30.00 (10.05) 5 F, 9 M Insomnia syndrome (DSM-IV and ICSD)
30 Nissen 2006 7 44.9 (4.1) 4 F, 3 M Primary insomnia
31 Marchetti 2006 30 23.2 (1.69) 15 F, 15 M Psychophysiological insomnia
32 Carney 2006 104 47.3 (16.8) 52 F, 52 M Primary insomnia
33 Lineberger 2006 88 45.39 (16.59) 44 F, 44 M Primary insomnia
34 Rioux 2006 11 48.00 (7.86) 5 F, 6 M Primary insomnia
35 Salin-Pascual 2006 6 26.6 (5.0) 4 F, 2 M Primary insomnia
36 Thacher 2006 10 34.7 (7.9) 7 F, 3 M Primary insomnia
37 Devoto 2005 7 22.6 (2) 4 F, 3 M Primary insomnia
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mental disorder. We would deﬁne Criterion D by the abuse of sub-
stances (eg, alcohol, caffeine, nicotine, or drugs), or by the use of
prescription medication. Lastly, we would deﬁne E as a currently
diagnosable sleep disorder, that is, narcolepsy/cataplexy, periodic
limb movements or restless legs, parasomnias, CRSDs, and insom-
nia disorder, and in conjunction with PSG screening (e.g., for sleep
apnea and periodic limb movements). Moreover, the presence of a
signiﬁcant health disorder, without associated sleep disruption, may
be unlikely given the overlap of sleep with general health [1,41].
While the ﬁnal three components (C, D, and E) seem particularly
applicable within a medical setting, they may not be appropriate
or necessary for use in all research settings, to ensure normal sleep-
ers are selected.
4.1. Deﬁning normal sleep: a research agenda
All of these components can be assessed in different ways,
such as by simple self-reports (eg, do you have insomnia?), a
personal history (eg, a previous diagnosis), evidence of symptoms
(eg, screening measures or PSG), and a diagnostic clinical inter-
view by trained experts. The precise levels of assessment applied
would depend on, for example, the number of subjects to be
tested, access to resources (eg, PSG and laboratory facilities),
and the experience of the researcher (e.g., in diagnosing the pres-
ence of a disorder). To aid standardization across the ﬁeld, we
suggest that precise deﬁnitions, exclusion criteria, and descriptive
information be reported as much as possible. Furthermore, the
use of standardized methods, such as the consensus sleep diary
[23], will help to aid comparisons between studies, as the precise
contents of sleep diaries can vary between laboratories. In addi-
tion, Edinger et al. [2] recommend reporting information on the
methods of recruitment and types of individuals, and the criteria
for normal sleep may need to be tailored, for example, in elderly
subjects [34]. Here, we suggest speciﬁc assessment tools thought
suﬃcient to identify normal sleepers, favoring questionnaire
methods, and aiming to reduce the burden on participants as
much as possible (see Fig. 2).
Means, standard deviations, and ranges are also recommended
to be reported for common sleep measures, as well as quantita-
tive thresholds, and the measures from which these are derived.
Indeed, we found sleep diaries to be often used, although full de-
scriptive information, as stated above, was not always reported.
Edinger et al. [2] report that most insomnia studies describe control
subjects as being without sleep complaints or insomnia. Exclu-
sions were found to be made for medical disorders that commonly
affect sleep (~50%), symptoms of psychiatric disorder (~42%), psy-
choactive agents (~23%), evidence of sleep timing disruption (~15%),
normal sleep values (~8.5%), or primary sleep disorders (<4%), and
>85% of samples were selected based on less than three of these
criteria, results that also appear broadly consistent with the present
review. However, in our sample of primary or physiological insom-
nia patients and controls, these values are higher overall, and in both
studies sleep timing measures are among the least reported. Here,
we suggest a deﬁnition of normal sleep for use with control sub-
jects in contrast to patients and in studies of healthy sleepers (eg,
sleep deprivation paradigms). Furthermore, this may be of partic-
ular importance in student populations, whose sleep has been
described as “erratic” [27].
A. The individual has 
no complaints of sleep 
disturbance or daytime 
symptoms attributable 
to unsatisfactory sleep.
B. The individual has 
a routine standard 
sleep/wake schedule 
characterized by regu-
lar bedtimes and rising 
times.
D. There is no evi-
dence of sleep disrup-
tion due to a substance 
exposure, use, abuse, 
or withdrawal.
E. There is no evi-
dence of a primary 
sleep disorder.
N/A (see A above)
N/A (see A above)
I. Insomnia disorder
II. Circadian rhythm sleep disorder
III. Sleep apnea
IV. Periodic limb movements/ restless legs
V. Parasomnia
C. There is no evi-
dence of a sleep-
disruptive medical or 
mental disorder.
I. > 5 hours, < 9 hours, and consistent with sleep need
II. N/A
III. SE > 85%; SOL, WASO and EMA < 30 mins
IV. Generally satisfied with sleep
V. No adverse effects associated with sleep
I. 22:00 — 01:00
III. Times + 1 hour, > 4 days a week
II. 06:00 — 09:00
N/A (see A above)
N/A (see A above)
I. Insomnia disorder
II. Circadian rhythm sleep disorder
III. Sleep apnea
IV. Periodic limb movements/ restless legs
V. Parasomnia
RDC (Edinger et al., 
2004)
Components Quantitative criteria Assessment methods
I. PSQI Q4 = 0 and < 9 hours; Q7 = 0 and Q8 < 2
I. STQ Q1..3
II. PSQI Q1, Q3 < 9 hours
III. PSQI C4,= 0; Q2 (inc. WASO, EMA) < 2
IV. PSQI Q6 < 2
V. SCI Q5,  Q6, Q7 > 2
II. STQ Q2..3
III. STQ Q1..7 and Q2.7
I. SCI total score < 17
II. Sleep algorithm (supplemental material 2)
III. PSG, sleep algorithm (supplemental material 2)
IV. PSG, sleep algorithm (supplemental material 2)
V. Sleep algorithm (supplemental material 2)
II. Time in bed
I. Sleep duration
IV. Subjective sleep impression
V. Associated daytime effects
III. Sleep continuity
III. Stability of sleep timing
II. Habitual rise times
I. Habitual bed times
I. PSQI total score < 7
I. PSQI total score < 7
VI. Sleep algorithm (supplemental material 2)VI. Narcolepsy V. Narcolepsy
Fig. 2. Deﬁnition of normal sleep and assessment tools.
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With regard to speciﬁc criteria of normal sleep parameters,
studies of insomnia have previously deﬁned criteria for normal sleep-
ers [29,42]. For example, papers may deﬁne sleep parameter
thresholds for insomnia subjects, such as a sleep-onset latency or
wake time after sleep onset duration of >30 min, total sleep time
<6 h, and sleep eﬃciency <85% [42,43], and it could be possible to
extrapolate criteria for normal sleepers from such reports. Further-
more, studies of sleep deprivation and epidemiological studies
provide evidence of the effects of sleepmanipulations and of normal
ranges within the general population. In the absence of existing
speciﬁcations for normal sleep, we would suggest the following def-
inition and possible measurement tools.
First, an individual does not meet the criteria for an existing sleep
disorder (ie, insomnia disorder, CRSD, sleep apnea, narcolepsy/
cataplexy, periodic limb movements or restless legs syndrome, or
a parasomnia). We suggest that the presence of periodic limbmove-
ments or restless legs syndrome and sleep apnea be assessed via
PSG. Espie [44] has developed a screening algorithm for CRSD,
parasomnias, restless legs syndrome or periodic limb movements,
sleep apnea, and narcolepsy (Appendix S2). The ISI [6] can be used
to assess the severity of insomnia symptoms in those with a sleep
complaint, and sleep complaints together with daytime sleepi-
ness may be indicative of a CRSD [45]. The sleep disorders
questionnaire can also be used to assess sleep apnea, narcolepsy,
and restless legs syndrome or periodic limb movements [46]. The
diagnosis of narcolepsy without cataplexy was described in greater
depth in 2014 [47]. In order to reduce the questionnaire burden on
research participants, we suggest that the brief screening algo-
rithm developed by Espie [44] be used to identify the likely presence
of narcolepsy, parasomnias, and CRSDs, and used to conﬁrm a lack
of sleep apnea, periodic limb movements, or restless legs syn-
drome. However, the questions here are minimal, and PSG would
provide a higher level of evidence. Furthermore, actigraphy can be
used to assess CRSD, and the Sleep Condition Indicator [48] can be
used to screen for insomnia disorder.
Second, an individual should not report any adverse daytime
effects associated with poor sleep, at least within the previous week.
Questionnaire measures could also be used to assess this, such as
question 7 of the ISI [6] or component 7 of the PSQI [5]. Third, an
individual should report general satisfaction with their sleep, which
can be assessed via the subjective components of a sleep diary [23],
component 1 of the PSQI [5], or question 4 of the ISI [6]. We suggest
that question 6 of the PSQI – “During the past month, how would
you rate your sleep quality overall?” – be used to assess general sleep
satisfaction. For no adverse daytime effects of poor sleep, PSQI ques-
tions 7, 8, and 9 could be used, with complaints less frequently than
once or twice a week. Alternatively, ISI question 3 could be used
to assess this, as could questions 5, 6, and 7 of the Sleep Condition
Indicator [48]. Fourth, we suggest speciﬁc deﬁnitions of sleep pa-
rameters to be indicative of normal sleep. In particular, we suggest
thresholds for sleep duration, sleep continuity, time in bed, and sleep
timing.
Typical sleep duration criteria are included, in keeping with a
recent description of sleep health [49], and as short sleep duration/
sleep restriction is linked to negative effects on health [1,41,50] and
mortality [51]. Individuals with insomnia, who also have a short sleep
duration, also seem to experience a more severe disorder (depres-
sion, heart and metabolic health) [52]. As an excessive sleep need,
or time in bed, can be indicative of mood disorders [53], we would
deﬁne normal sleep by a sleep duration of <9 h a night and >5 h a
night (in the absence of diminished sleep continuity). Further-
more, the amount of sleep typically achieved should be consistent
with sleep need (cf. Refs. [1,49]), and this is affected by factors such
as age [27,34].
Sleep restriction also affects the ability to judge sleep need well
[54]. For example, a studywith “naturally short sleepers” foundmany
potential subjects to report that their short sleep duration was as-
sociated with work or caregiving, or poor physical or mental health.
Indicators of naturally short sleep duration included these sleep-
ers not seeming to make up for lost sleep at weekends and having
identical Epworth Sleepiness Scale (ESS) scores as control sub-
jects. These subjects slept on average for ≤6 h a night, and they were
found to show signiﬁcantly greater evidence of hypomanic symp-
toms [55]. These studies taken together indicate that there are few
people who are naturally short sleepers and those who show evident
signs of mood disruption. However, these guidelines will require
testing, and ultimately there will be a trade-off between sensitiv-
ity and speciﬁcity. We would suggest that sleep timing be assessed
via questions 1 and 3 of the PSQI or via the STQ [38]. Sleep dura-
tion could be assessed via the PSQI, with question 8 (daytime
sleepiness) used to assess whether sleep need is being met. These
measures combined implicitly set limits on time in bed.
On measures of sleep continuity, sleep-onset latency, wake time
after sleep onset, and early-morning awakenings should each be
<30 min, with a sleep eﬃciency of >85%. These components can be
assessed via sleep diary [23] or the PSQI [5]. With regard to sleep
scheduling, ordinarily, the timing of sleep should be consistent with
a 9 am to 5 pm work pattern. We would suggest a typical bedtime
of 22:00–01:00, with a rise time of 06:00–09:00. Furthermore, these
times should not vary markedly, with sleep times being consis-
tent, within an hour, most days a week. The STQ [38] and sleep
diaries [23] can be used to assess sleep timing and stability. However,
ideally, all components of normal sleep could be captured by the
use of a single measure, and sleep diaries are not always practical.
While a comprehensive deﬁnition of good sleep in contrast to normal
sleep is beyond the scope of the present review, we suggest docu-
menting applied criteria, to allow for future work in this area (see
Fig. 3). Furthermore, these components are consistent with those
recently identiﬁed by Buysse [49] (sleep duration, eﬃciency/
continuity, timing, alertness, and satisfaction), as being important
for sleep health. A sleep health questionnaire was also described
[49].
Additional criteria might be needed for the screening/selection
of good sleepers, such as the endorsement of good sleep, along-
side the absence of complaint. Good sleepers and normal sleepers
could be somewhat different subject groups, and this could be worth
investigating further. For example, three hypotheses may be made
based on their differences. First, good sleepers may be less likely
to report or experience sleep disruption. Second, the effects of sleep
loss on daytime functioning could be less severe, or minimal, for
good sleepers. Third, good sleepers could have a general resilience
against poor health and towards well-being. For example, the Ford
Insomnia Response to Stress Test (FIRST) can be used to assess vul-
nerability towards sleep disruption [56], and the importance of sleep
adaptability has been recognized theoretically [25,49]. Understand-
ing this resilience to poor sleep/insomnia could have important
implications for individuals and organizations, where sleep disrup-
tion may be expected.
As a result of this review, we have developed the Revised Re-
search Criteria for Deﬁning Normal Sleeper Controls (Fig. 3) for use
with control subjects. Here, we suggest four main components of
normal sleep, that is, sleep disruption, circadian disruption, sleep
disorders, and general health, which includes each of the ﬁve com-
ponents previously identiﬁed [2].Wewould deﬁne sleep quality with
the following three subcomponents: sleep duration and continu-
ity, subjective sleep impression, and its impact on functioning. Sleep
timing includes habitual bedtimes and rise times, their impact, and
sleep timing stability. With regard to other sleep disorders, four key
sleep disorders aremost relevant to screen for: narcolepsy/cataplexy,
sleep-disordered breathing or sleep apnea, parasomnias, and rest-
less legs and periodic limbmovements. Insomnia disorder and CRSDs
can be assumed to be covered within sleep quality and sleep timing
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Yes/ No Levels* Definitions/ exclusions
1. Sleep quality Sleep duration 0 1     2     3     4 > 6 hours, consistent with sleep need
Time in bed 0 1     2     3     4 < 9 hours
Sleep continuity 0 1     2     3     4 SE > 85%; SOL, WASO, EMA < 30 mins
Subjective sleep impression 0 1     2     3     4 Generally satisfied
Associated daytime effects 0 1     2     3     4 No adverse effects
2. Sleep timing Habitual bed times 0 1     2     3     4 22:00 — 01:00
Habitual rise times 0 1     2     3     4 06:00 — 09:00
Stability of sleep timing 0 1     2     3     4 + 1 hour, > 4 days a week
Associated daytime effects 0 1     2     3     4 No adverse effects
3. Sleep disorders Insomnia disorder 0 1     2     3     4 e.g. PSQI < 7
Circadian rhythm sleep disorder 0 1     2     3     4 e.g. sleep algorithm
Sleep apnea 0 1     2     3     4 e.g. PSG, sleep algorithm
PLMS/ RLS 0 1     2     3     4 e.g. PSG, sleep algorithm
Narcolepsy 0 1     2     3     4 e.g. sleep algorithm
Parasomnia 0 1     2     3     4 e.g. sleep algorithm
Optional:
4. General health Physical health 0 1     2     3     4 e.g. cardiovascular disease
Mental health 0 1     2     3     4 e.g. DSM-IV disorders
Medication use 0 1     2     3     4 e.g. prescription medication




1 = simple self reports e.g. are you a satisfied with your sleep? (Y/N)
2 = personal history e.g. past diagnosis, family history
3 = evidence of symptoms e.g. questionnaires, PSG, blood work
4 = diagnosable disorder e.g. expert—diagnosed disorder (screening interview)
Fig. 3. Revised research diagnostic criteria for deﬁning normal sleeper controls.
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(see Image 3). Under general health, we combined C and D of the
RDC, and included mental and physical health with medication use
and substance abuse. However, extreme levels of substance abuse
would overlap with mental health (ie, at the level of a substance
abuse disorder), and substance abuse would include illicit drugs as
well as, for example, nicotine, alcohol, and caffeine.
In summary, while results suggest that in general the methods
of assessing normal sleepers cover the key components of normal
sleep as speciﬁed by Edinger et al. [2], there is variability in the exact
procedures used by different laboratories. However, an important
limitation of the present results is that review papers used a well-
deﬁned insomnia sample, and resultsmay differ if a broader inclusion
criterion was used. It should also be noted that some of the studies
reviewedmay have begun before the publication of the RDC in 2004,
and they were published afterwards. Nonetheless, even within the
current sample, important issues in identifying controls were iden-
tiﬁed. Different ﬁelds could also apply different deﬁnitions to normal
sleepers/control subjects, and we agree with Edinger et al. [2] that
“due to this lack of standardization, synthesizing results of multi-
ple. . .studies is a diﬃcult if not impossible task.” As a ﬁrst step,
greater reporting of descriptive sleep information would aid in clari-
fying the exact nature of control groups. If screening of sleep
disruption and timing can be clariﬁed, additional methods could
be redundant, and this would help reduce the burden on controls.
While existing measures, such as the PSQI [5] and ISI [6], provide
ranges for a lack of sleep disruption, these measures are not used
consistently. Furthermore, as predominately global measures, these
questionnaires do not tend to be reported at the item level, and they
do not address all components of the RDC [2]. The use of these cri-
teria for normal sleep would help clarify how the components of
the RDC are assessed, aiding the understanding of how insomnia
develops, as well as the nature of good sleep itself, by helping to
standardize this ﬁeld.
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